title: Preparing for an epidemic: cancer care in an aging population.
abstract: The Institute of Medicine's (IOM) Committee on Improving the Quality of Cancer Care: Addressing the Challenges of an Aging Population was charged with evaluating and proposing recommendations on how to improve the quality of cancer care, with a specific focus on the aging population. Based on their findings, the IOM committee recently released a report highlighting their 10 recommendations for improving the quality of cancer care. Based on those recommendations, this article highlights ways to improve evidence-based care and addresses rising costs in health care for older adults with cancer. The IOM highlighted three recommendations to address the current research gaps in providing evidence-based care in older adults with cancer, which included (1) studying populations which match the age and health-risk profile of the population with the disease, (2) legislative incentives for companies to include patients that are older or with multiple morbidities in new cancer drug trials, and (3) expansion of research that contributes to the depth and breadth of data available for assessing interventions. The recommendations also highlighted the need to maintain affordable and accessible care for older adults with cancer, with an emphasis on finding creative solutions within both the care delivery system and payment models in order to balance costs while preserving quality of care. The implementation of the IOM's recommendations will be a key step in moving closer to the goal of providing accessible, affordable, evidence-based, high-quality care to all patients with cancer.
authors.affiliation: From the Section of Hospital Medicine, Department of Medicine, Program in the Economics of Cancer, University of Chicago, Chicago IL; Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA.
authors.forename: Ya-Chen Tina
authors.initials: YC
authors.lastname: Shih
authors.affiliation: From the Section of Hospital Medicine, Department of Medicine, Program in the Economics of Cancer, University of Chicago, Chicago IL; Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA.
authors.forename: Arti
authors.initials: A
authors.lastname: Hurria
mesh_terms: D017677:Age Distribution; D000367:Age Factors; D000368:Aged; D000375:Aging; D003362:Cost-Benefit Analysis; D003695:Delivery of Health Care / Q000191:economics / Q000458:organization & administration* / Q000592:standards; D058872:Epidemics; D019317:Evidence-Based Medicine / Q000191:economics / Q000458:organization & administration* / Q000639:trends; D017048:Health Care Costs; D006801:Humans; D008495:Medical Oncology / Q000191:economics / Q000458:organization & administration* / Q000592:standards; D009369:Neoplasms / Q000175:diagnosis / Q000191:economics / Q000453:epidemiology / Q000628:therapy*; D017410:Practice Guidelines as Topic; D058996:Quality Improvement / Q000458:organization & administration; D011787:Quality of Health Care / Q000458:organization & administration